Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS
This study has been completed.
Study NCT00202241 Information provided by Queen's University
First Received on September 13, 2005. Last Updated on December 21, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV
AIDS
Lipodystrophy
Hyperlipidemia
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Lipid Metabolism Disorders
Metabolic Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Metabolic
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
testosterone injection
Additional drug interventions recognized in this trial
Methyltestosterone
Protease Inhibitors
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Enzyme Inhibitors
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Queen's University
Ontario Ministry of Health and Long Term Care
Back to top of Main Content
